About Us

Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

A Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Social Media

Bluesky • Facebook • Instagram • LinkedIn • YouTube

Meet the Laser Focus World Team

Editorial

Sales

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology
My Watchlist
Indicators
Industrial Laser Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

SkyWater Signs Production Agreement with Nautilus Biotechnology to Fabricate Novel Biomedical Devices

By: via Business Wire

Nautilus program moves from Advanced Technology Services to Wafer Services, demonstrating success of SkyWater’s Technology as a Service model

SkyWater Technology (NASDAQ: SKYT), the trusted technology realization partner, today announced it has signed a production agreement with Nautilus Biotechnology, Inc. to supply silicon-based microfluidic bio chips for Nautilus’ proteome analysis system. This marks a significant milestone for SkyWater as Nautilus transitions from its Advanced Technology Services (ATS) custom development program to SkyWater’s Wafer Services program. Through SkyWater’s Technology as a Service (TaaS) business model, the company provides customers with a unique combination of strong technical capability, rigorous product development processes and secure manufacturing, all within the same U.S. operation.

A more comprehensive understanding of proteins and their function may become an important contributor to precision medicine and in the understanding of biological functions, discovery of disease markers, and verifying drug targets. Advances in protein analysis are increasingly being co-developed across industries through advanced semiconductor manufacturing capabilities. Custom-designed nanostructures, with features orders of magnitude smaller than advanced plastics, can be produced on a large scale and precisely tailored in size, shape, and arrangement to support specific tasks. This approach not only enhances system performance but also leads to savings in materials and costs, directly benefiting companies pursuing next-generation protein analysis by improving efficiency and reducing resource usage.

Advances in MEMS, microfluidics, low-power electronics and materials science are driving innovation for the biomedical industry. SkyWater leverages its extensive CMOS and MEMS process capabilities to meet the customized technology needs of its customers. The company’s TaaS model enables chip designers to engage with the foundry early in the technology lifecycle by performing development work in a production environment. This approach accelerates time to market, ensures that quality is designed in from the start and scales easily to volume. SkyWater is certified to the ISO 13485 Quality Standard for Medical Devices to support the design, development and fabrication of DNA sequencing, lab on chip and other biomedical applications.

“As we continue to experience growth in our innovation-focused ATS development business, we are pleased to see one of our development-stage life science customers begin their transition to Wafer Services production. Our TaaS model allows customers to continue to innovate for future designs on the same tools and processes as their current product, enabling a ‘lab-to-fab' environment,” said Ross Miller, SVP, Commercial and A&D Business at SkyWater. “We look forward to continuing to support Nautilus as they move toward the commercial availability of their groundbreaking proteome analysis platform. It’s exciting to be working with their team on efforts to revolutionize biomedicine and positively impact the health and lives of people around the world.”

About SkyWater Technology

SkyWater (NASDAQ: SKYT) is a U.S.-based semiconductor manufacturer and a DMEA-accredited Category 1A Trusted Foundry. SkyWater’s Technology as a Service model streamlines the path to production for customers with development services, volume production and heterogeneous integration solutions in its world-class U.S. facilities. This pioneering model enables innovators to co-create the next wave of technology with diverse categories including mixed-signal CMOS, read-out ICs, rad-hard ICs, power management, MEMS, superconducting ICs, photonics, carbon nanotubes and interposers. SkyWater serves growing markets including aerospace & defense, automotive, biomedical, cloud & computing, consumer, industrial and IoT. For more information, visit: www.skywatertechnology.com.

SkyWater Technology Forward-Looking Statements

This press release contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements that are based on the Company’s current expectations or forecasts of future events, rather than past events and outcomes, and such statements are not guarantees of future performance. Forward-looking statements are subject to risks, uncertainties and assumptions, which may cause the Company’s actual results, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. Key factors that could cause the Company’s actual results to be different than expected or anticipated include, but are not limited to, factors discussed in the “Risk Factors” section of its annual report on Form 10-K and quarterly reports on Form 10-Q, and in other documents that the Company files with the SEC, which are available at http://www.sec.gov. The Company assumes no obligation to update any forward-looking statements, which speak only as of the date of this press release.

SKYT-CORP

Contacts

More News

View More
Chewy Stock: Why Analysts Say Boring May Be the Best Buy
Via MarketBeat
Topics Economy
Tickers BBY CHWY
Apple Stock Positioned for Holiday Gains With iPhone 17 Boost
Via MarketBeat
Topics Artificial Intelligence World Trade
Tickers AAPL MSFT
Fundamentals Say Bet Against the Recent Adobe Downgrade
Via MarketBeat
Tickers ADBE
AppLovin Stock Momentum Builds With $800+ Analyst Price Target
Via MarketBeat
Tickers APP UBS
Which National Chains Do People Wish Were in Their State? [2025 Survey]
Via MarketBeat
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.